Recruitment and eligibility in a Phase 1 early Alzheimer's disease trial of Sabirnetug
{{output}}
Introduction: Historically underrepresented racial and ethnic groups may face a higher risk and burden of dementia but continue to be underrepresented in Alzheimer's disease (AD) clinical research. Recent efforts have been insuf... ...
